Effective September 2026, People’s Hospital 115 will operationalize a new facility at the Hoa Hung site (formerly the District 10... Read more
Category: Uncategorized
AstraZeneca secures FDA approval for Saphnelo autoinjector in lupus care
The US Food and Drug Administration (FDA) has approved a subcutaneous autoinjector version of Saphnelo (anifrolumab) for adult patients suffering... Read more
Sun Pharma to acquire Organon for $11.75bn in landmark pharmaceutical deal
Sun Pharmaceutical Industries has entered into a definitive agreement to acquire Organon for an enterprise valuation of $11.75 billion in... Read more
Sanofi’s MS therapy secures European endorsement following US rejection
European drug regulators have issued a positive review for Sanofi’s experimental multiple sclerosis (MS) treatment. This move comes after the... Read more
FDA approves Regeneron’s Otarmeni as the first gene therapy for genetic deafness
On April 23, 2026, the US Food and Drug Administration (FDA) authorized Otarmeni (lunsotogene parvec-cwha), the first-ever gene therapy for... Read more
Eli Lilly enters $2.3 billion agreement to acquire Ajax Therapeutics, boosting blood cancer pipeline
Eli Lilly has agreed to acquire Ajax Therapeutics in a deal valued at up to $2.3 billion, featuring an upfront... Read more
Recalled cosmetics continue to be sold openly on e-commerce platforms
Despite explicit recall and destruction orders from the Ministry of Health due to missing Product Information Files (PIF), numerous prohibited... Read more
Ministry of Health proposes new specialized inspection procedures to enhance management transparency
The Ministry of Health is currently seeking public feedback on a draft Circular outlining the authority and procedures for specialized... Read more
Protagonist and J&J secure FDA nod for life-changing oral psoriasis pill
The United States Food and Drug Administration (FDA) has granted approval for icotrokinra, marketed under the brand name ICOTYDE, as... Read more









